Colin Shannon, EVP, Global Clinical Operations at PHARMACEUTICAL PRODUCT DEVELOPMENT INC (PPDI), sold 32,500 shares at $33.97 ($1.1M) on 2007-02-09, disclosed to the SEC on 2007-02-12.
Open-market sale of $1.1M PPDI by EVP, Global Clinical Operations. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $33.97 | 4,221 | $143K | 12.9% |
| 2 | $34.00 | 8,442 | $287K | 25.9% |
| 3 | $34.11 | 6,331 | $216K | 19.5% |
| 4 | $34.16 | 4,221 | $144K | 13.0% |
| 5 | $34.25 | 2,110 | $72K | 6.5% |
| 6 | $34.38 | 7,175 |
| $247K |
| 22.2% |
| Total | $34.14 avg | 32,500 | $1.1M | 100% |
| Filing → |
| PRAH | SELL | 2021-06-17 | $62.9M | — | Filing → |
| PRAH | SELL | 2021-06-03 | $2.2M | — | Filing → |
| PRAH | SELL | 2020-08-17 | $1.2M | — | Filing → |